Skip to main content

Conjunctivitis Treatment Market size to Reach USD 5.72 Billion by 2031 as OTC Eye Care Availability and Allergic Eye Conditions Influence Market Trends

Mordor Intelligence has published a new report on the conjunctivitis treatment market, offering a comprehensive analysis of trends, growth drivers, and future projections.

-- Introduction 

According to Mordor Intelligence, the conjunctivitis treatment market size was valued at USD 4.53 billion in 2025 and is estimated to grow from USD 4.71 billion in 2026 to USD 5.72 billion by 2031, reflecting steady conjunctivitis treatment market growth during the forecast period. The conjunctivitis treatment market forecast highlights consistent demand for therapies that address one of the most frequently diagnosed eye disorders across healthcare systems. Increasing patient awareness of eye health, wider availability of ophthalmic medicines, and expanding access to eye care services are shaping the conjunctivitis treatment industry landscape. 

Conjunctivitis, often referred to as pink eye, remains a common condition affecting children and adults worldwide. The condition may arise due to bacterial infection, viral exposure, or allergic reactions, which creates continuous demand for treatments such as eye drops, ointments, and supportive therapies. Because of the high incidence of eye infections and allergies in many regions, the conjunctivitis treatment market size continues to expand steadily. 

Conjunctivitis Treatment Market Trends 

Increasing Over-the-Counter Availability of Ophthalmic Treatments 

One of the important conjunctivitis treatment market trends is the growing availability of over-the-counter ophthalmic products. Many pharmacies now offer anti-infective and anti-allergy eye drops that allow patients to address mild symptoms without requiring immediate physician visits. 

Preservative-Free Formulations Influencing Conjunctivitis Treatment Market Share 

Another noticeable development in the conjunctivitis treatment market is the rising focus on preservative-free ophthalmic formulations. Traditional eye drops often contain preservatives to maintain stability, but some patients experience irritation or sensitivity to these ingredients. 

Increasing Allergic Eye Conditions Supporting Market Growth 

Environmental changes and longer allergen seasons have contributed to a growing number of allergic eye conditions. This shift has had a direct influence on conjunctivitis treatment market trends, particularly in regions experiencing rising pollen exposure and urban air pollutants. 

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/conjunctivitis-treatment-market?utm_source=industrytoday  

Conjunctivitis Treatment Market Segmentation 

By Disease Type 

  • Allergic conjunctivitis 
  • Bacterial conjunctivitis 
  • Viral conjunctivitis 

By Formulation Type 

  • Ointments 
  • Eye drops 
  • Oral and parenteral drugs 

By Geography 

  • North America 
  • Europe 
  • Asia-Pacific 
  • Middle East and Africa 
  • South America 

Conjunctivitis Treatment Market Key Players 

The conjunctivitis treatment market is moderately concentrated, with established pharmaceutical companies maintaining strong distribution networks and ophthalmology portfolios. These companies focus on research activities, product line expansion, and partnerships to maintain their position in the industry. 

Leading Companies in the Conjunctivitis Treatment Market 

  • AbbVie Inc. 
  • Novartis AG 
  • Bausch + Lomb 
  • Alembic Pharma 
  • NicOx S.A. 

Conclusion 

The conjunctivitis treatment market continues to grow steadily as healthcare systems focus on managing common eye conditions that affect millions of people each year. Increasing access to ophthalmic therapies, expanded pharmacy distribution channels, and rising patient awareness all support the positive outlook for the market size. 

Overall, the market forecast reflects stable demand for therapies addressing bacterial, viral, and allergic eye conditions. With healthcare providers emphasizing early diagnosis and effective symptom management, the market growth trajectory is expected to remain steady across both developed and emerging healthcare regions. 

Industry Related Reports 

Topical Scar Treatment Market: 

 https://www.mordorintelligence.com/industry-reports/topical-scar-treatment-market?utm_source=industrytoday 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com  

https://www.mordorintelligence.com/   

Contact Info:
Name: Mordor Intelligence
Email: Send Email
Organization: Mordor Intelligence
Address: 11th Floor, Rajapushpa Summit, Nanakramguda rd
Phone: 16177652493
Website: https://www.mordorintelligence.com/

Release ID: 89186005

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release that require attention or if there is a need for a press release takedown, we kindly request that you notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or guide you through the removal process. Ensuring accurate and reliable information is fundamental to our mission.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.06
+2.40 (1.15%)
AAPL  253.05
+2.93 (1.17%)
AMD  198.70
+5.31 (2.75%)
BAC  47.09
+0.37 (0.79%)
GOOG  303.44
+1.99 (0.66%)
META  625.85
+12.14 (1.98%)
MSFT  399.01
+3.46 (0.87%)
NVDA  184.96
+4.71 (2.61%)
ORCL  154.95
-0.16 (-0.10%)
TSLA  397.61
+6.41 (1.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.